Agents of Biological and Chemical Terrorism
Children have myriad unique needs compared to adults during all types of disasters. Many of these unique needs emanate from the fundamental differences between adults and children in terms of anatomy and physiology. In the event of a biological or chemical terrorism event, the difficulties which arise from these differences are complicated by a lack of weight-based medication dosing guidelines, a lack of appropriate sized supplies, and a lack of evidence-based practices in children. The risk of biological, chemical, or radiological weapon use has increased as terrorists become more familiar with these agents and their potential for harm. Biological agents are invisible to the eye, odorless, potentially lethal in particulate form; natural organisms are readily available, and can be disguised as natural disasters to spread fear and disease. Chemical agents rapidly attack the body’s critical physiological centers, disabling or killing victims. Potential biochemical agents of terrorism include; Bacillus anthracis (anthrax), Yersinia pestis (plague), tularemia, small pox, botulinum toxin, nerve agents and cyanide. Healthcare providers need to be familiar with clinical presentation and life-saving treatment modalities, as well as the precautions necessary to prevent contamination and transmission to healthcare workers and to proactively plan for the needs of children during a disaster.
KeywordsBiological weapons Chemical weapons Nerve agents Small pox Category A agents
The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as necessarily reflecting the views of the U.S. Department of Defense, the U.S. Department of Health and Human Services, or their component services, agencies, and institutions.
- 6.Cieslak TJ, Christopher GW, Eitzen EM. Bioterrorism alert for healthcare workers. In: Fong IW, Alibek K, editors. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York: Springer Science & Business Media Inc; 2005. p. 215–34.Google Scholar
- 7.Emmad NA, Udeani JC. Biologic toxins. Top Emerg Med. 2002;24(2):72–8.Google Scholar
- 9.Dang C, Kare J, Shneiderman A, Dang ABC. Chemical warfare agents. Top Emerg Med. 2002;24(2):25–39.Google Scholar
- 14.Ciraulo DL, Frykberg ER, Feliciano DV, Knuth TE, Richart CM, Westmoreland CD, Williams KA. A survey assessment of the level of preparedness for domestic terrorism and mass casualty incidents among eastern association for the surgery of trauma members. J Trauma. 2004;56(5):1033–41.PubMedCrossRefGoogle Scholar
- 16.Kabsai D, Kare J. Prehospital disaster management: implications for weapons of mass destruction. Top Emerg Med. 2002;24(3):37–43.Google Scholar
- 19.US Army Medical Research Institute of Chemical Defense. Field management of chemical casualties. 2nd ed. Aberdeen Proving Ground: Chemical Casualty Care Division USAMRICD; 2000. p. 96–135.Google Scholar
- 20.US Army Medical Research Institute of Infectious Diseases. Medical management of biological casualties handbook. 6th ed. Fort Detrick, Frederick: US Army Medical Research Institute of, Infectious Diseases; 2005. p. 33–48.Google Scholar
- 21.CDC. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51:1024–6.Google Scholar